As we head into Q4, we look back on what has been an exciting and busy period for Arrotek over the past year. Here are the highlights:
Expanding Our Business
2024 started with the announcement that Arrotek co-founder Mark Pugh had been appointed the CEO of Theragenics Corporation, the parent company of Arrotek. The Theragenics Corporation, based in the US, specialises in minimally invasive medical devices and serves a wide range of customers in the medical device and healthcare industries.
We also rebranded the former NeedleTech brand as Arrotek, strengthening our offering and cementing our position in the market with two centres of excellence on two continents – our Centre of Excellence for Metals Manufacturing in Boston in the US and our plastics centre of excellence in Ireland. We launched a new and improved website as part of the expansion of the Arrotek brand.
New strategic partnerships have been developed during 2024, including with Nano4Imaging. Our facility in the USA will take over final production of Nano4Imaging’s MRI-compatible guidewire.
Our parent company Theragenics also started work on a new USD $10 million manufacturing facility in Costa Rica that will further enhance Arrotek’s capabilities and the services we can offer to medical device customers in the US, Europe, and around the world.
Facility Investments
Over the past year, we have invested in the capabilities of both our US and Irish facilities. This includes opening two new cleanrooms in our facility in Boston – an ISO Class 7 cleanroom and an ISO Class 6 cleanroom.
We also opened a fourth cleanroom in our Irish manufacturing facility in Sligo. This new ISO Class 7 cleanroom is our largest in Europe at 300 sqm.
In addition to opening new cleanrooms, we also built a new 90 sqm packing area in our Irish facility and invested in our rapid prototyping capabilities in the US.
Awards
This year so far has been another year of awards for Arrotek. We were named Life Sciences Company of the Year (Medium) at the Life Sciences Industry Awards in Ireland and Best Medical Device Development Company – Northwest Ireland at the 2024 Irish Enterprise Awards.
An Exciting Year and Ambitious Plans for the Future
Arrotek’s Global Sales Manager said: “What we have achieved as a company over the past year has been phenomenal, the expansion of the Arrotek brand in the US, and the massive investments the company has made in Ireland, the US, and Costa Rica to deliver on the needs of our ever-growing customer base.
“Even though this has been an exciting year for Arrotek, we have ambitious plans for the coming year and beyond that will be even more exciting. “As we reflect, it’s important to highlight the hard work of our fantastic global team at Arrotek and to thank our customers for their continued support. We look forward to building on our relationships over the coming years and welcoming new customers and commercial partnerships.”
